Financial statements Dna
Balance sheet data of DNA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 9 141 345,65 | 8 797 230,23 | 9 441 492,69 | 9 324 613,97 | 9 285 130,10 | 10 181 601,14 |
| A. Fixed assets | 8 437 181,59 | 8 511 699,97 | 8 716 588,52 | 8 808 204,91 | 8 789 530,91 | 9 045 394,60 |
| B. Current assets | 704 164,06 | 285 530,26 | 724 904,17 | 516 409,06 | 495 599,19 | 1 136 206,54 |
| C. Share capital contributions (basic funds) | - | - | - | - | 0,00 | 0,00 |
| D. Own shares (stocks) | - | - | - | - | 0,00 | 0,00 |
| Total liabilities | 9 141 345,65 | 8 797 230,23 | 9 441 492,69 | 9 324 613,97 | 9 285 130,10 | 10 181 601,14 |
| A. Equity | 5 302 139,08 | 6 903 707,61 | 7 024 987,01 | 7 077 691,74 | 7 121 711,90 | 7 520 439,62 |
| B. Liabilities and provisions for liabilities | 3 839 206,57 | 1 893 522,62 | 2 416 505,68 | 2 246 922,23 | 2 163 418,20 | 2 661 161,52 |
| I. Long-term liabilities | 550 000,00 | 1 595 107,85 | 1 569 979,00 | 1 751 744,09 | 1 655 419,29 | 2 343 896,98 |
| II. Short-term liabilities | 3 288 871,57 | 291 982,42 | 617 241,29 | 284 641,38 | 296 143,12 | 262 725,60 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.